December 26, 2017 | Chinese pharmaceutical firm WuXi AppTec Group will team up with Merck Serono, a subsidiary of Merck KGaA, to set up a biotech/pharma incubator in Israel in early 2018, Calcalist reported this week. The startup incubator, called Explore Bio, will be situated in the Israeli town of Yavne, where Merck Sorono already has a location. The incubator will evaluate investments, assist with drug development, assess market demand, and offer early-stage mentoring, according to the report. Each Israeli firm will receive seven million dollars in an initial investment from the company. Israeli businessman Mori Arkin and life sciences VC fund Pontifax are also part of the venture.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments